Jeffrey Janus, President, has a proven track record extending over 20 years of creating profitable commercial cell based businesses and building corporate value as a result. He was one of the leaders in the development and commercialization of Clonetics Corporation and the Clonetics brand of human cell products for both research and clinical use. That company was successfully sold in 1995 after ten consecutive years of profitable growth exceeding 20%. Mr. Janus foresaw the need for human cells in therapy and created businesses in the contract manufacturing of human cells and culture media and human cells for clinical use. He has organized businesses providing unique research products using living cells to conduct drug screening in the pharmaceutical industry, product testing in the consumer products industry and basic research at Universities and Government laboratories. Critical staff from Clonetics Corporation agreed to join Lifeline to pursue the advancement of stem cell product development and manufacture for research and therapeutic use and to re-establish a successful management team. Mr. Janus has a M.B.A. and a Bachelor's degree in Biochemistry.

Elena Revazova, Ph.D., M.D., Director of Research and Development, is one of the world's experts in creating immortal cell lines.  Dr. Revazova was a leading cell biologist in the Soviet Union before coming to the U.S. eight years ago. She is now a US citizen. Dr. Revazova has successfully established human stem cell lines from unfertilized oocytes. She has personally created or supervised the creation and patenting of over 50 different cell models that include, stomach, colon, liver, renal, lung, muscle and skin cells and has also created stable human cell lines from tumors of various organs and tissues Dr. Revazova’s access to the leading scientists and research institutes in the former Soviet Union has proven to be an invaluable asset to Lifeline. Those relationships are expected to continue to add value, even though the Company’s base of operations is in the United States.

William B. Adams, Managing Member and CFO, has 40 years of experience in the corporate consulting and financing arenas. Mr. Adams has provided seed capital and secondary and bridge financing to numerous start-up companies both individually and as a manager of various private investment partnerships.
Mr. Adams is a co-founder of Dimensional Planning Group, a financial planning company; WaveTec Vision Systems, an ophthalmic device company, Lifeline Cell Technology, LLC, which is now a subsidiary of International Stem Cell Corporation. Previously, Mr. Adams was an accountant at Ernst & Ernst (now Ernst & Young). Mr. Adams holds a B.S. in Accounting from California State University, Long Beach and is on the alumni Board of Ernst & Young in Los Angeles and is on the board of directors of the Los Angles Council of Boy Scouts of America.
 

Alexa Dillberger, General Manager, California Facilities, has over 25 years experience in the commercialization and sales of research products to researchers in the biotechnology industry, including 11 years leading sales for normal human cell and media products. She has laboratory experience, especially in the isolation and derivation of specific human cells from tissue. Her technical and sales background make Alexa aware of the issues that are important to researchers in the field and uniquely able to set up the technical service that is so important to make Lifeline a resource to its customers.

Francisco Bustamante, General Manager, Maryland Facilities, has over 15 years of experience in the operations of biotechnology companies. His experience includes senior management positions in the areas of manufacturing, procurement, planning, warehousing, distribution and project management. He possesses experience in the manufacture and logistics of cell culture products, biological instruments, molecular biology kits and diagnostics. He has led key projects in the areas of MRP implementation, ISO compliance, product development, product transfer, and change leadership to name a few. His industry experience includes Clonetics, BioWhittaker, Cambrex, Digene and Meso Scale Diagnostics. Mr. Bustamante received his B.S. degree in Biology from the University of San Diego and an M.B.A. from Frostburg State University, Frostburg, Maryland.

Jeremy Hammond, Director of Quality Control, has over 20 years of experience developing human cell based products and the quality control systems critical for their manufacture. He created and implemented the quality control systems that were responsible for making Clonetics products world renown for consistency and reproducibility. These quality control systems are the standard for companies currently manufacturing human cell based products. Mr. Hammond is expert in the field of both serum-containing and serum-free media formulations and in the purification of human cells, fields critical for therapeutic applications of cell culture technology.

Hoyt Matthai, Manufacturing Advisor, has over 20 years of experience directing and establishing manufacturing facilities for the production of cell culture products, class I and III medical devices, biologicals, and cell based pharmaceuticals.  Mr. Matthai has extensive experience in developing and validating manufacturing systems for human, animal, and genetically modified cell cultures.  Under his direction, cell culture products have been manufacturing for pharmaceutical use, clinical In Vitro Diagnostics, and research use in large scale operations including an 82,000-sq. ft. manufacturing facility, a 65,000-sq. ft. warehouse, and over 230 personnel.  His industry work experience includes HEM Research, Flow Laboratories, BioWhittaker, Clonetics, Cambrex, Neuralstem, MetriGenix, Gene Logic, ATCC and Lifeline.  Mr. Matthai received his undergraduate degree from Florida State University and his M.S. degree from Hood College, Frederick, Maryland. 

Scott Boyer, Marketing Advisor, is the Executive Director of Marketing for Utah State University Extension and marketing consultant to the cell culture industry.  He has over 20 years of successful cell culture marketing, market research, product management, distribution management, and customer care experience in academic, government, clinical, and pharmaceutical applications.  Specific products include normal human cell systems for research, classical media for research, class I and class III cell cultures for clinical applications. His industry work experience includes Clonetics, BioWhittaker, Cambrex, HyClone, Fisher Scientific, and Lifeline.  Mr. Boyer received his undergraduate degree from San Diego State University, and an M.B.A. from Frostburg State University, Frostburg, Maryland.